The ongoing coronavirus disease 2019 (COVID-19) pandemic has spurred intensive vaccine-related research. As yet, no targeted, safe and effective antivirals
Read moreSars
New COVID-19 variants can evade antibodies that work against original form of the virus
New research at Washington University School of Medicine in St. Louis indicates that three new, fast-spreading variants of the virus
Read morePreclinical study finds immune benefit in unrefrigerated Soligenix coronavirus vaccines
Many vaccines have been developed to boost immunity against severe acute respiratory syndrome (SARS-CoV-2). However, a major concern during vaccine
Read moreMultiple COVID-19 variants of concern have reached Houston, Texas
New research by a team at Houston Methodist Hospital in the United States has modeled the aggressive genomic sequencing of
Read morePfizer-BioNTech SARS-CoV-2 vaccine effective for wide range of Covid-19–related outcomes
The Pfizer-BioNTech mRNA vaccine was shown to be 95% effective in preventing severe COVID-19 infection in clinical trials. However, given
Read moreSARS-CoV-2 modulates host cell central carbon metabolism for reproduction
A team of scientists from Sweden and India has recently characterized the host cell metabolic alterations associated with severe acute
Read moregeneric compazine from india no prescription
Prior to the emergence of new mutants of the coronavirus, such as the British variant B.1.1.7, the SARS-CoV-2 variant named
Read moreResearchers investigate the duration of the immune response to SARS-CoV-2
The optimal timeframe for donating convalescent plasma for use in COVID-19 immunotherapy, which was given emergency use authorization by the
Read moreAntibody and T cell response to SARS-CoV-2 persist up to 8 months: Study of Ski Resort Ischgl
The first instance of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreak in Austria was observed in the Ski
Read moreStudy reports lasting immune response in convalescent COVID-19 patients
Using different types of assays, researchers found both cellular and humoral immune responses for up to eight months in coronavirus
Read more